IMM 1.64% 30.0¢ immutep limited

Report attached, page-20

  1. 8,960 Posts.
    lightbulb Created with Sketch. 6836
    Ahjay , At anytime now with these excellent results building the FDA could Halt the trial and allow the patients on standard of care to receive C-Vac , C-Vac gains FDA approval , that is what will wake the market and shoot the share price sky high, those not in PRR will be very disappointed .
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.